ADDPLAN DF Consortium

At a Glance
  • Status: Active Consortium
  • Year Launched: 2013
  • Initiating Organization: ICON plc
  • Initiator Type: Industry
  • No disease focus
  • Location: North America


ADDPLAN® is a stand-alone software, using data to design, simulate, and analyze adaptive clinical trials with ease. The ADDPLAN DF Consortium is comprised of Novartis Pharma AG, Janssen Pharmaceuticals Inc., Eli Lilly, and Aptiv Solutions. The consortium’s objective is to deliver a comprehensive platform and process map for the integrated design and execution of innovative exploratory phase adaptive trials.


The consortium will work collaboratively to address the challenges that arise in phases II and III of pharmaceutical trials by:

-Developing new statistical methodologies for the design of innovative dose-finding clinical trials with an emphasis on adaptive designs

-Focusing on enhancing the trial execution technologies required to handle the multiple adaptations integral to complex adaptive dose-finding trials

-Integrating and validating these methodologies into ADDPLAN DF software for the design, planning, and analysis of dose finding trials, and ensuring that these designs are easily implemented through AptivAdvantage™, the Aptiv Solutions proprietary trial execution platform

Consortium History

ADDPLAN DF Consortium was founded in 2013

Structure & Governance

ADDPLAN is adaptive trail design software developed by ICON, a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar, and genetic organizations.

Points of Contact

Niamh Murphy
Director of Corporate Communications
Tel: +353-1-2912000

Sponsors & Partners

ICON plc (Sponsor)

Novartis Pharma AG

Janssen Pharmaceuticals Inc.

Eli Lilly

Aptiv Solutions



Last Updated: 06/19/2017

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.